Authors:
MCGIFFIN DC
NAFTEL DC
KIRKLIN JK
MORROW WR
TOWBIN J
SHADDY R
ALEJOS J
ROSSI A
FRAZIER E
HEILMAN KJ
PACHEAO DK
STERBA R
LATSON L
FRASER C
FITZGERALD R
PLATT L
APPLETON RS
KURBAT M
FRIEDMAN B
FRICKER FJ
FLEEGER T
PAHL E
STAPLETON P
RING WS
COPELAND M
CLARK B
SANDS B
ADDONIZIO LJ
DOUGLAS J
KNAUF D
HARKER K
WEST LJ
GILDNER J
CALDWELL RL
FLASPOHLER T
CHINNOCK RE
JOHNSTON J
ROBIE S
MULLEN GM
LAFF MA
MCGREGOR CGA
HENKE P
SUDDENDORF S
TIMMONS M
MOSKOWITZ W
FLATTERY M
CABALKA A
OKANE M
HOFFMAN F
SEIMERS N
BRUHN P
REUTZEZ T
COURTNEY M
RELLER MD
STARLING R
HOLT C
BULLOCK E
ZAHKA KG
HANISCH D
CANTER C
BASH S
STUBLES CE
FAULKNER S
STANSTROM ML
BERNSTEIN D
GAMBERG P
PRICE J
MCGIFFIN DC
BOUCEK MM
MASHBURN C
LUNA M
CROWLEY D
CALLOW L
BOUCEK R
DISANO S
DODD DA
BURGER J
Citation: Dc. Mcgiffin et al., PREDICTING OUTCOME AFTER LISTING FOR HEART-TRANSPLANTATION IN CHILDREN - COMPARISON OF KAPLAN-MEIER AND PARAMETRIC COMPETING RISK ANALYSIS, The Journal of heart and lung transplantation, 16(7), 1997, pp. 713-722
Citation: P. Cremin et al., MYELODYSPLASIA AND ACUTE MYELOID-LEUKEMIA FOLLOWING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER USING MITOXANTRONE AND METHOTREXATE WITH OR WITHOUT MITOMYCIN, Annals of oncology, 7(7), 1996, pp. 745-746
Citation: Pa. Daly et al., THERAPY-RELATED ACUTE MYELOID-LEUKEMIA FOLLOWING ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER USING MITOXANTRONE AND METHOTREXATE WITH OR WITHOUT MITOMYCIN, European journal of cancer, 31A, 1995, pp. 55-55
Authors:
GRAVES L
FLATTERY M
OKI J
FLORA D
ISLEY WL
Citation: L. Graves et al., A COMPARISON OF THE CLINICAL PRACTICES BETWEEN THE GENERAL MEDICAL CLINIC AND DIABETES SPECIALTY CLINIC OF AN INNER-CITY TEACHING HOSPITAL, Diabetes, 43, 1994, pp. 10000085-10000085